291 related articles for article (PubMed ID: 35062247)
1. Association between SARS-CoV-2 Seroprevalence in Nursing Home Staff and Resident COVID-19 Cases and Mortality: A Cross-Sectional Study.
Wisniak A; Menon LK; Dumont R; Pullen N; Regard S; Dubos R; Zaballa ME; Baysson H; Courvoisier D; Kaiser L; Pittet D; Azman AS; Stringhini S; Guessous I; Balavoine JF; Kherad O; The SEROCoV-Work Study Group
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062247
[TBL] [Abstract][Full Text] [Related]
2. The BNT162b2 vaccine is associated with lower new COVID-19 cases in nursing home residents and staff.
Domi M; Leitson M; Gifford D; Nicolaou A; Sreenivas K; Bishnoi C
J Am Geriatr Soc; 2021 Aug; 69(8):2079-2089. PubMed ID: 33955567
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of SARS-CoV-2 antibodies, associated factors, experiences and attitudes of nursing home and home healthcare employees in Switzerland.
West EA; Kotoun OJ; Schori LJ; Kopp J; Kaufmann M; Rasi M; Fehr J; Puhan MA; Frei A;
BMC Infect Dis; 2022 Mar; 22(1):259. PubMed ID: 35296242
[TBL] [Abstract][Full Text] [Related]
4. Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study.
Cabezas C; Coma E; Mora-Fernandez N; Li X; Martinez-Marcos M; Fina F; Fabregas M; Hermosilla E; Jover A; Contel JC; Lejardi Y; Enfedaque B; Argimon JM; Medina-Peralta M; Prieto-Alhambra D
BMJ; 2021 Aug; 374():n1868. PubMed ID: 34407952
[TBL] [Abstract][Full Text] [Related]
5. Rates of COVID-19 Among Residents and Staff Members in Nursing Homes - United States, May 25-November 22, 2020.
Bagchi S; Mak J; Li Q; Sheriff E; Mungai E; Anttila A; Soe MM; Edwards JR; Benin AL; Pollock DA; Shulman E; Ling S; Moody-Williams J; Fleisher LA; Srinivasan A; Bell JM
MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):52-55. PubMed ID: 33444301
[TBL] [Abstract][Full Text] [Related]
6. Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective Cohort Study.
Meyers E; Deschepper E; Duysburgh E; De Rop L; De Burghgraeve T; Van Ngoc P; Digregorio M; Delogne S; Coen A; De Clercq N; Buret L; Coenen S; Sutter A; Scholtes B; Verbakel JY; Cools P; Heytens S
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366456
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of SARS-CoV-2 in healthcare workers from outpatient facilities and retirement or nursing homes in a Swiss canton.
Zürcher K; Mugglin C; Suter-Riniker F; Keller PM; Egger M; Müller S; Fluri M; Hoffmann M; Fenner L
Swiss Med Wkly; 2021 Aug; 151():w30021. PubMed ID: 34495604
[TBL] [Abstract][Full Text] [Related]
8. The demography and characteristics of SARS-CoV-2 seropositive residents and staff of nursing homes for older adults in the Community of Madrid: the SeroSOS study.
Candel FJ; Barreiro P; San Román J; Del Mar Carretero M; Sanz JC; Pérez-Abeledo M; Ramos B; Viñuela-Prieto JM; Canora J; Martínez-Peromingo FJ; Barba R; Zapatero A;
Age Ageing; 2021 Jun; 50(4):1038-1047. PubMed ID: 33945607
[TBL] [Abstract][Full Text] [Related]
9. Estimation of Transmission of COVID-19 in Simulated Nursing Homes With Frequent Testing and Immunity-Based Staffing.
Holmdahl I; Kahn R; Hay JA; Buckee CO; Mina MJ
JAMA Netw Open; 2021 May; 4(5):e2110071. PubMed ID: 33988707
[TBL] [Abstract][Full Text] [Related]
10. Cross-Sectional Analysis of Risk Factors for Outbreak of COVID-19 in Nursing Homes for Older Adults in the Community of Madrid.
San Román J; Candel FJ; Del Mar Carretero M; Sanz JC; Pérez-Abeledo M; Barreiro P; Viñuela-Prieto JM; Ramos B; Canora J; Barba R; Zapatero A; Martínez-Peromingo FJ;
Gerontology; 2023; 69(2):163-171. PubMed ID: 35654010
[TBL] [Abstract][Full Text] [Related]
11. Asymptomatic carriage rates and case fatality of SARS-CoV-2 infection in residents and staff in Irish nursing homes.
Kennelly SP; Dyer AH; Noonan C; Martin R; Kennelly SM; Martin A; O'Neill D; Fallon A
Age Ageing; 2021 Jan; 50(1):49-54. PubMed ID: 32986806
[TBL] [Abstract][Full Text] [Related]
12. [Seroprevalence, risk factors and clinical presentation after the first wave of COVID-19 in nursing homes of the UNIVI group: The SEROCOVID study].
Harboun M; Verdun S; Brénière V; Luquel L; Jourdan M; De Malherbe A
Rev Med Interne; 2022 Feb; 43(2):75-81. PubMed ID: 34728092
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors Associated With SARS-CoV-2 Infections, Hospitalization, and Mortality Among US Nursing Home Residents.
Mehta HB; Li S; Goodwin JS
JAMA Netw Open; 2021 Mar; 4(3):e216315. PubMed ID: 33787905
[TBL] [Abstract][Full Text] [Related]
14. Short-term impact of nursing home SARS-CoV-2 vaccinations on new infections, hospitalizations, and deaths.
Mor V; Gutman R; Yang X; White EM; McConeghy KW; Feifer RA; Blackman CR; Kosar CM; Bardenheier BH; Gravenstein SA
J Am Geriatr Soc; 2021 Aug; 69(8):2063-2069. PubMed ID: 33861873
[TBL] [Abstract][Full Text] [Related]
15. Screening Strategies to Reduce COVID-19 Mortality in Nursing Homes.
Dong S; Jutkowitz E; Giardina J; Bilinski A
JAMA Health Forum; 2024 Apr; 5(4):e240688. PubMed ID: 38669030
[TBL] [Abstract][Full Text] [Related]
16. Factors Associated With Racial Differences in Deaths Among Nursing Home Residents With COVID-19 Infection in the US.
Gorges RJ; Konetzka RT
JAMA Netw Open; 2021 Feb; 4(2):e2037431. PubMed ID: 33566110
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and COVID-19-Associated Hospitalization Among Residents in Nursing Homes - National Healthcare Safety Network, United States, October 2023-February 2024.
Franklin D; Barbre K; Rowe TA; Reses HE; Massey J; Meng L; Dollard P; Dubendris H; Stillions M; Robinson L; Clerville JW; Slifka KJ; Benin A; Bell JM
MMWR Morb Mortal Wkly Rep; 2024 Apr; 73(15):339-344. PubMed ID: 38635474
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 Infections and Deaths among Connecticut Nursing Home Residents: Facility Correlates.
Li Y; Temkin-Greener H; Shan G; Cai X
J Am Geriatr Soc; 2020 Sep; 68(9):1899-1906. PubMed ID: 32557542
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
[TBL] [Abstract][Full Text] [Related]
20. Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.
Angulo FJ; Finelli L; Swerdlow DL
JAMA Netw Open; 2021 Jan; 4(1):e2033706. PubMed ID: 33399860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
